During the past decade, Yamagata Prefectural Central Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yamagata Prefectural Central Hospital" #1 sponsor was "Haruhiko Fukuda" with 5 trials, followed by "Japan Clinical Oncology Group" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored and "Associations for Establishment of Evidence in Interventions" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yamagata Prefectural Central Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 9 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Japan Clinical Oncology Group" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "European Society of Surgical Oncology" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Yamagata Prefectural Central Hospital" are "Colorectal Cancer" (3 trials), "Gastric Cancer" (3 trials), "Gastric Neoplasm" (2 trials), "Aortic Dissection" (1 trials) and "Colon Cancer Liver Metastasis" (1 trials). Many other conditions were trialed in "Yamagata Prefectural Central Hospital" in a lesser frequency.

Most popular intervention types in "Yamagata Prefectural Central Hospital" are "Drug" (15 trials), "Procedure" (7 trials), "Device" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "5FU+l-leucovorin" (1 trials), "A: Radiotherapy alone" (1 trials), "B: CBDCA and Radiotherapy" (1 trials) and "Cefmetazole (drug)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yamagata Prefectural Central Hospital" are 19 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Yamagata Prefectural Central Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Yamagata Prefectural Central Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Yamagata Prefectural Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".